Restelli, U., Fabbiani, M., Di Giambenedetto, S., Nappi, C., & Croce, D. (2017). Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial. Clinicoecon Outcomes Res.
Citação norma ChicagoRestelli, Umberto, Massimiliano Fabbiani, Simona Di Giambenedetto, Carmela Nappi, and Davide Croce. "Update of the Budget Impact Analysis of the Simplification to Atazanavir + Ritonavir + Lamivudine Dual Therapy of HIV-positive Patients Receiving Atazanavir-based Triple Therapies in Italy Starting From Data of the Atlas-M Trial." Clinicoecon Outcomes Res 2017.
MLA引文Restelli, Umberto, et al. "Update of the Budget Impact Analysis of the Simplification to Atazanavir + Ritonavir + Lamivudine Dual Therapy of HIV-positive Patients Receiving Atazanavir-based Triple Therapies in Italy Starting From Data of the Atlas-M Trial." Clinicoecon Outcomes Res 2017.